Clinical trials sponsored by AIDS Malignancy Consortium

Phase breakdown

Conditions studied

Recruiting trials led by AIDS Malignancy Consortium

• A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
  NCT04139304 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa
  NCT04704648 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
  NCT05077527 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · 11 locations
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations

Common questions

How many trials is AIDS Malignancy Consortium recruiting for?

AIDS Malignancy Consortium is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.